Periodontal Disease and Colorectal Cancer
PD and CRC
The Influence of Periodontal Disease and Periodontal Treatment on Colorectal Cancer
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this interventional study is to determine the impact of periodontal disease and periodontal treatment on patients with colorectal cancer. The main questions were:
- 1.Does periodontal treatment affect the levels of C-reactive protein in the blood of patients undergoing cancer treatment?
- 2.Can the investigators isolate periodontal pathogenic bacteria Fusobacterium nucleatum and Porphyromonas gingivalis from the mucosa of cancerous colon tissue using the method of quantitative culture?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2024
CompletedFirst Submitted
Initial submission to the registry
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedJanuary 29, 2025
November 1, 2024
11 months
January 15, 2025
January 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
CRP levels
Measurement of CRP levels in the blood of patients with colorectal cancer at the first examination by the oncological surgeon, on the first and second day after colon resection, and at the first follow-up examination by the oncological surgeon.
From the enrollment to the date of first documented progression at 16 weeks
The proportion of Fusobacterium nucleatum and Porphyromonas gingivalis
Using quantitative culture for detection of periodontal bacteria Fusobacterium nucleatum and Porphyromonas gingivalis in the cancer altered intestinal musoca and comparing it with the status in the periodontal pocket
From the first dental exam to the resective colon surgery at 2 weeks
Study Arms (2)
Patients with colorectal cancer who recived periodontal treatment
EXPERIMENTALPatients with colorectal cancer were treated for periodontal disease based on the condition of their periodontal tissues.
Patients with colorectal cancer who did not recived periodontal treatment
NO INTERVENTIONDue to ethical concerns, we selected patients who had completed cancer therapy before the start of our study for the control group, and who met the inclusion criteria based on the completed questionnaires.
Interventions
Based on the results of the dental examination and the diagnosis of the periodontal tissue condition according to the new classification of periodontal disease, we performed appropriate non-surgical treatment of periodontal disease, provided oral hygiene instruction, and took a biofilm sample from the deep periodontal pocket. We then collected a sample of the altered mucosa during bowel surgery for colorectal cancer and conducted a microbiological investigation using quantitative culture to compare the presence of Fusobacterium nucleatum and Porphyromonas gingivalis in the pariodontal pocket and altered intestinal mucosa.
Eligibility Criteria
You may qualify if:
- colorectal cancer, scheduled for surgical treatment
- consent to participate
- fiilled questionnaire
- Recorded CRP results at the first examination, after surgery, and at the first follow-up examination.
You may not qualify if:
- under 18 years old
- periodontal treatment in the past 12 months
- antibiotic therapy in the last 3 months
- edentulism
- advanced stage cancer, scheduled for palliative care
- chemotherapy or radiotherapy prior to surgical procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Ljubljana, Division of stomatology, Center for oral disease and periodontology
Ljubljana, Slovenija, 1000, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rok Schara, associate professor, doctor of dental medicine
University Medical Cneter Ljubljana, Division of Stomatology, Center of oral disease and periodontology,
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2025
First Posted
January 29, 2025
Study Start
October 25, 2023
Primary Completion
September 30, 2024
Study Completion
November 5, 2024
Last Updated
January 29, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
sex, age, clinical diagnosis and location of colorectal cancer, histological diagnosis of the cancer, stage of cancer, BMI, Smoker or not, possible concomitant systemic diseases